{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:04:29Z","timestamp":1791993869426,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014807","name":"Nagoya University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.resinv.2025.06.002","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:54:25Z","timestamp":1749196465000},"page":"711-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical and complete remission in patients with severe asthma with 24-month dupilumab treatment"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4646-5378","authenticated-orcid":false,"given":"Tomoko","family":"Tajiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirono","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Amakusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keima","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Fukumitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kanemitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1538-5551","authenticated-orcid":false,"given":"Yutaka","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Oguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.06.002_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202109-2205PP","article-title":"Global initiative for asthma strategy 2021: executive summary and rationale for key changes","volume":"205","author":"Reddel","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02583-2021","article-title":"Asthma remission: what is it and how can it be achieved?","volume":"60","author":"Thomas","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.06.002_bib3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1183\/23120541.00620-2020","article-title":"Remission of adult-onset asthma is rare: a 15-year follow-up study","volume":"6","author":"Almqvist","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2025.06.002_bib4","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.rmed.2007.06.011","article-title":"Outcome and severity of adult onset asthma--report from the obstructive lung disease in northern Sweden studies (OLIN)","volume":"101","author":"R\u00f6nmark","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.rmed.2016.06.017","article-title":"A 12-year prognosis of adult-onset asthma: sein\u00e4joki adult asthma study","volume":"117","author":"Tuomisto","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaci.2017.03.034","article-title":"Clinical predictors of remission and persistence of adult-onset asthma","volume":"141","author":"Westerhof","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2025.06.002_bib7","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jaip.2020.11.013","article-title":"Remission and changes in severity over 30 Years in an adult asthma cohort","volume":"9","author":"Tupper","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2025.06.002_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(23)00415-0","article-title":"Pioneering a paradigm shift in asthma management: remission as a treatment goal","volume":"12","author":"Lommatzsch","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(24)00293-5","article-title":"Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis","volume":"13","author":"Shackleford","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107348","article-title":"Severe asthma clinical remission after biologic treatment with anti-IL4\/IL13: a real-life experience","volume":"217","author":"Portacci","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1164\/rccm.202311-2192OC","article-title":"Exploring definitions and predictors of severe asthma clinical remission post-biologic in adults","volume":"210","author":"Perez-de-Llano","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107720","article-title":"Dupilumab responder types and predicting factors in patients with type 2 severe asthma: a real-world cohort study","volume":"231","author":"Bult","year":"2024","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/jcm13010291","article-title":"Clinical remission in patients affected by severe eosinophilic asthma on dupilumab therapy: a long-term real-life study","volume":"13","author":"Quarato","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib14","first-page":"253","article-title":"Clinical response and remission in patients with severe asthma treated with biologic therapies","volume":"165","author":"Hansen","year":"2024","journal-title":"Chest (Am Coll Chest Physicians)"},{"key":"10.1016\/j.resinv.2025.06.002_bib15","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/jpm13061020","article-title":"Clinical asthma remission obtained with biologics in real life: patients' prevalence and characteristics","volume":"13","author":"Sposato","year":"2023","journal-title":"J Personalized Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib16","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.jaip.2023.05.047","article-title":"Response to biologics and clinical remission in the adult German asthma net severe asthma Registry cohort","volume":"11","author":"Milger","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2025.06.002_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2024.10.009","article-title":"Dupilumab induces long-term on-treatment clinical remission in patients with type 2 asthma","volume":"13","author":"Pavord","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2025.06.002_bib18","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.jaip.2024.03.049","article-title":"Long-term effectiveness of anti-IL-4R therapy following suboptimal response to anti-IL-5\/5R therapy in severe eosinophilic asthma","volume":"12","author":"Gates","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2025.06.002_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.alit.2024.02.002","article-title":"Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: a prospective, observational study","volume":"73","author":"Tajiri","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.06.002_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.alit.2023.02.006","article-title":"Executive summary: Japanese guidelines for adult asthma (JGL) 2021","volume":"72","author":"Niimi","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.06.002_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.06.002_bib22","first-page":"600","article-title":"Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application","volume":"80","author":"Takishima","year":"1981","journal-title":"Chest (Am Coll Chest Physicians)"},{"key":"10.1016\/j.resinv.2025.06.002_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2025.06.002_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1150162","article-title":"Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: analysis of the REDES study","volume":"14","author":"Pavord","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2025.06.002_bib25","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3390\/jcm12082900","article-title":"A real-world study of achievement rate and predictive factors of clinical and deep remission to biologics in patients with severe asthma","volume":"12","author":"Oishi","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4168\/aair.2024.16.5.462","article-title":"Update on inflammatory biomarkers for defining asthma phenotype","volume":"16","author":"Sim","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.resinv.2025.06.002_bib27","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/j.jaip.2023.07.041","article-title":"Severe asthma network Italy definition of clinical remission in severe asthma: a delphi consensus","volume":"11","author":"Canonica","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2025.06.002_bib28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000319566","article-title":"Association of alveolar nitric oxide levels with pulmonary function and its reversibility in stable asthma","volume":"81","author":"Matsumoto","year":"2011","journal-title":"Respiration (Basel)"},{"key":"10.1016\/j.resinv.2025.06.002_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.05.00034505","article-title":"General considerations for lung function testing","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.06.002_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/rccm.200211-1268OC","article-title":"Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma","volume":"168","author":"Niimi","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2006.07.012","article-title":"Davis BE: mechanisms of airway hyperresponsiveness","volume":"118","author":"Cockcroft","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2025.06.002_bib33","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1183\/09031936.98.11051064","article-title":"Eosinophilic inflammation in cough variant asthma","volume":"11","author":"Niimi","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.06.002_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.alit.2021.09.003","article-title":"Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma","volume":"71","author":"Tajiri","year":"2022","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.06.002_bib35","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S2213-2600(21)00322-2","article-title":"Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study","volume":"10","author":"Wechsler","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2025.06.002_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pharmthera.2019.05.002","article-title":"A review on the pathophysiology of asthma remission","volume":"201","author":"Carpaij","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.resinv.2025.06.002_bib38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2003.016246","article-title":"Childhood factors associated with asthma remission after 30 year follow up","volume":"59","author":"Vonk","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2025.06.002_bib39","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01974-2016","article-title":"Childhood factors associated with complete and clinical asthma remission at 25 and 49 years","volume":"49","author":"Carpaij","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.06.002_bib40","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jaci.2018.09.038","article-title":"Remission of persistent childhood asthma: early predictors of adult outcomes","volume":"143","author":"Wang","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2025.06.002_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1398-9995.2006.01082.x","article-title":"Are risk factors of childhood asthma predicting disease persistence in early adulthood different in the developing world?","volume":"61","author":"Sekerel","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.resinv.2025.06.002_bib42","article-title":"The effect of biologics in lung function and quality of life of patients with united airways disease: a systematic review","volume":"3","author":"Dom\u00ednguez-Ortega","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.resinv.2025.06.002_bib43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.anai.2024.07.001","article-title":"Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma: a prospective study","volume":"133","author":"Tajiri","year":"2024","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:50:16Z","timestamp":1762383016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2212534525000826"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.06.002","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and complete remission in patients with severe asthma with 24-month dupilumab treatment","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}